Protease-activated receptor 2 signalling pathways: a role in pain processing

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.18, Iss.1, 2014-01, pp. : 15-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of mast cells, stem cell factor and protease-activated receptor-2 in tubulointerstitial lesions in IgA nephropathy

By Liu Hong Liu Fuyou Peng Youming Liu Yinghong Li Lingyan Tu Xiwen Cheng Meichu Xu Xiangqing Chen Xing Ling Guanghui Sun Lin

Inflammation Research, Vol. 59, Iss. 7, 2010-07 ,pp. : 551-559

Springer Publishing Company

Access to resources Recommend Favorite

Suppression by protease-activated receptor-2 activation of gastric acid secretion in rats

By Nishikawa H. Kawai K. Nishimura S. Tanaka S. Araki H. Al-Ani B. Hollenberg M.D. Kuroda R. Kawabata A.

European Journal of Pharmacology, Vol. 447, Iss. 1, 2002-06 ,pp. : 87-90

Elsevier

Access to resources Recommend Favorite

Multiple roles for protease-activated receptor-2 in gastric mucosa

By Kawabata Atsufumi

Inflammopharmacology, Vol. 10, Iss. 4-6, 2002-12 ,pp. : 343-349

VSP

Access to resources Recommend Favorite

Protease-Activated Receptors as Therapeutic Targets in Visceral Pain

Current Neuropharmacology, Vol. 11, Iss. 6, 2013-12 ,pp. : 598-605

Bentham Science Publishers

Access to resources Recommend Favorite

Vorapaxar: a novel protease-activated receptor-1 inhibitor

By Gurbel Paul A Jeong Young-Hoon Tantry Udaya S

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1445-1453

Informa Healthcare

Access to resources Recommend Favorite